A new allergy medication was recently approved by the FDA -- the first new medication in years available for the treatment of seasonal and perennial allergies in adults and children 12 years of age and older. QNASL, an HFA aerosol corticosteroid nasal spray, is the first nasal spray on the market that is being touted as a "dry" nasal spray. Because QNASL is non-aqueous, it should result in much less dripping out of the nose -- or down the throat -- after use. This feature of many of the "wet" (aqueous) nasal sprays that are currently available is a problem for many nasal allergy sufferers.
QNASL should be available with a doctor's prescription in April 2012, according to TEVA Pharmaceuticals, the manufacturer of the medication. So, if you suffer from spring allergies, like millions of Americans, schedule an appointment with your doctor soon. QNASL samples should be available in a matter of a couple of weeks. I know I'll be giving QNASL out to my allergy patients this allergy season.
Read more:
- Nasal Corticosteroid Sprays
- Overview of Allergic Rhinitis Treatment
- Spring Allergies
No comments:
Post a Comment